Obesity & Diabetes Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity & Diabetes Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Diabetes Therapy
Innocoll files IND for CollaRx Gentamicin for infected diabetic foot ulcers
December 11th, 2006
Innocoll, Inc., announced that it has filed an investigational new drug (IND) application for its CollaRx Gentamicin as a topical antibiotic treatment for diabetic foot ulcers that are clinically infected or at risk of infection. CollaRx Gentamicin is a biodegradable and fully resorbable gentamicin-collagen sponge formulated and manufactured using Innocoll's proprietary CollaRx technology. Upon application to a wound, the product releases gentamicin, a broad-spectrum, concentration-dependent aminoglycoside antibiotic, for local action. This achieves a high concentration of drug at the target tissue, while maintaining low systemic levels well below the toxicity...
Source: Obesity & Diabetes Week (2006-12-11)
|
